Skip to content

Management team

MARK C. POZNANSKY, MD, PHD, FCRP, FIDSA

DIRECTOR

Dr. Poznansky is an expert physician scientist and medical innovator who has combined these expertise together to found and direct the Vaccine and Immunotherapy Center (VIC) at Massachusetts General Hospital to foster accelerated bench to bedside research and the development of novel vaccines and immunotherapies for…

MICHAEL V. CALLAHAN, MD, MSPH, DTM&H (U.K.)

DIRECTOR, CLINICAL TRANSLATION & MASS-CASUALTY THERAPEUTICS

Dr. Michael Callahan is a Staff Physician at MGH in internal medicine and infectious disease, and a clinical subject matter expert for international clinical trials for the Assistant Secretary of Public Health Preparedness (ASPR) of the Dept. of Health and Human Services, Washington, DC. Dr. Callahan has conducted federal-funded basic science and clinical…

ANN E. SLUDER, PHD

ASSOCIATE DIRECTOR

Dr. Sluder joined VIC in 2015 with a focus on discovery and development projects that connect basic science outcomes to therapeutic solutions, often in collaboration with other academic and industry partners. She also manages VIC finances, and works with other members of the VIC management team on strategic program initiatives.

JEFFREY A. GELFAND, MD

SENIOR SCIENTIST

Dr. Gelfand is a Physician at MGH and Professor of Medicine, Part Time at Harvard Medical School. Dr. Gelfand has conducted laboratory and clinical research in immunology, inflammation and infection for over 40 years. Dr. Gelfand has focused on vaccines for infectious diseases and cancer. He initiated the programs on the…

PHOEBE INGRAM, B.ED

PROJECT & ADMINISTRATIVE COORDINATOR

Phoebe Ingram joined VIC in 2015 to provide support to the management and research teams. She serves as the Executive Assistant to the Director and implements, maintains and coordinates Center processes.